VPIM
OTLK icon

Vanguard Personalized Indexing Management’s Outlook Therapeutics OTLK Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.48K Buy
31,492
+15,887
+102% +$6.87K ﹤0.01% 2163
2025
Q4 		$24.7K Buy
15,605
+1,713
+12% +$2.74K ﹤0.01% 1930
2025
Q3 		$14.7K Buy
13,892
+659
+5% +$1.14K ﹤0.01% 1973
2025
Q2 		$21.2K Buy
13,233
+1,937
+17% +$3.09K ﹤0.01% 1902
2025
Q1 		$13.8K Sell
11,296
-655
-5% -$1.15K ﹤0.01% 1811
2024
Q4 		$22.6K Buy
+11,951
New +$49.2K ﹤0.01% 1759

Other funds holding OTLK

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $126M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NMC
Nine Masts Capital Central, Hong Kong $693M AUM 31.93% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

Vanguard Personalized Indexing Management's OTLK Position: Q1 2026 in Review

Vanguard Personalized Indexing Management increased its Outlook Therapeutics (OTLK) stake by 102% in Q1 2026, buying an estimated $6.87K and bringing the position to 31,492 shares worth $6.48K. The position accounts for ﹤0.01% of the portfolio, ranked #2163.

Vanguard Personalized Indexing Management first reported a position in OTLK in Q4 2024 and has held it in 6 quarters since. The position peaked at $24.7K in Q4 2025. 54 funds tracked by Wall St. Rank hold OTLK as of Q1 2026.

  • Vanguard Personalized Indexing Management held 31,492 shares of Outlook Therapeutics worth $6.48K as of Q1 2026.
  • Vanguard Personalized Indexing Management bought 15,887 Outlook Therapeutics shares in Q1 2026, an estimated $6.87K.
  • Outlook Therapeutics made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q1 2026, its #2163 holding.
  • Vanguard Personalized Indexing Management first reported a position in Outlook Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • Vanguard Personalized Indexing Management's Outlook Therapeutics position peaked at $24.7K in Q4 2025.
  • 54 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.